tirzepatide glp-1 gip vs. Semaglutide: What You Should Know Lose up to 20% of your body weight with this simple What is Tirzepatide? It's a

Key Takeaways Obesity increases visceral fat levels, which can disrupt normal hormonal function

Objective SURMOUNT-1 Trial To evaluate the efficacy and safety of tirzepatide versus placebo in overweight adults/adults with obesity who did not have diabetes

For microdosing, they may increase the dosage after 8-10 weeks

Your provider should evaluate whether continued treatment addresses an ongoing health need

Some individuals may experience a weight reduction of less than 5%, while others may achieve more substantial losses

Storage considerations that affect injection comfort Compounded tirzepatide typically requires refrigeration , and cold medication causes significantly more injection site discomfort than room-temperature medication